Compare KWR & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KWR | AORT |
|---|---|---|
| Founded | 1918 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 1985 | 1993 |
| Metric | KWR | AORT |
|---|---|---|
| Price | $134.61 | $45.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $149.25 | $49.36 |
| AVG Volume (30 Days) | 135.6K | ★ 414.1K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,864,242,000.00 | $422,646,000.00 |
| Revenue This Year | $3.44 | $14.91 |
| Revenue Next Year | $4.15 | $10.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.08 | ★ 9.81 |
| 52 Week Low | $95.91 | $21.97 |
| 52 Week High | $161.47 | $48.04 |
| Indicator | KWR | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 50.13 |
| Support Level | $133.49 | $45.06 |
| Resistance Level | $138.90 | $47.33 |
| Average True Range (ATR) | 4.86 | 1.37 |
| MACD | 0.24 | -0.18 |
| Stochastic Oscillator | 54.42 | 40.53 |
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.